- Home
- ITRG vs LXRX Comparison
ITRG vs LXRX Comparison
Compare ITRG & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | LXRX |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.5M | 541.5M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | ITRG | LXRX |
|---|---|---|
| Price | $3.50 | $1.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $4.00 | $3.23 |
| AVG Volume (30 Days) | ★ 2.2M | 2.2M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $219,125,000.00 | $70,864,000.00 |
| Revenue This Year | $709.65 | $66.55 |
| Revenue Next Year | $36.86 | N/A |
| P/E Ratio | $45.52 | ★ N/A |
| Revenue Growth | N/A | ★ 1255.21 |
| 52 Week Low | $0.79 | $0.28 |
| 52 Week High | $3.52 | $1.66 |
Technical Indicators
Market Signals| Indicator | ITRG | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.21 | 50.90 |
| Support Level | $2.73 | $1.28 |
| Resistance Level | $3.12 | $1.52 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 96.83 | 43.59 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.